← All trials
NCT00002582
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 1993
- Primary completion
- —
- Completion date
- Apr 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 6000
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- University of LondonLead sponsor
- University of GlasgowStudy chair
- University of LeedsStudy chair
- Cancer Research CampaignStudy chair
- Scottish Cancer Therapy NetworkCollaborator
- Cancer Research CampaignCollaborator
- Yorkshire Regional Clinical Trials Research UnitCollaborator
- Royal Marsden Hospital NHS TrustStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.